Oncolytics Biotech 的抗癌免疫疗法 pelareorep 显示出有希望的结果。 Oncolytics Biotech shows promising results with its cancer-fighting immunotherapy, pelareorep.

癌症研究正在取得进展,重点是污染与癌症的联系,特别是非吸烟者肺癌。 Cancer research is advancing with a focus on pollution's link to cancer, especially lung cancer in non-smokers. 癌症治疗市场预计到2030年将达到285.96亿美元。 The cancer therapy market is projected to reach $285.96 billion by 2030. 其免疫疗法Pelareorep将难以治疗的肿瘤转化成反应更灵敏的肿瘤, Oncolytics Biotech Inc. has shown promising results with its immunotherapy, pelareorep, which converts hard-to-treat tumors into more responsive ones. 在试验中,pelareorep在胰腺癌病人中达到33%的响应率,可以与标准的化疗相结合,为治疗带来新的希望。 In trials, pelareorep achieved a 33% response rate in pancreatic cancer patients and can be combined with standard chemotherapy, offering new hope for treatment.